Sign in
4

Changes in Ownership

Werewolf Therapeutics, Inc. Filed Acc 0001134657-26-000001

Director sold 78,377 shares at an average $0.62 ($48,431)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
EVNIN LUKE Director 2025-12-30 Sale 10b5-1 −34,847 $0.61 $21,257 2,515,827 I: show line 1 in the form
EVNIN LUKE Director 2025-12-31 Sale 10b5-1 −24,962 $0.62 $15,476 2,490,865 I: show line 2 in the form
EVNIN LUKE Director 2026-01-02 Sale 10b5-1 −18,568 $0.63 $11,698 2,472,297 I: show line 3 in the form
Open-market sales · 78,377 sh · avg $0.62 · $48,431
Loading xslF345X05/form4-01022026_100128.xml…